# 5-Fluoro-2'-Deoxcyctidine and Tetrahydrouridine to Treat Patients With Advanced Cancer

> **NCT00359606** · PHASE1 · COMPLETED · sponsor: **City of Hope Medical Center** · enrollment: 58 (actual)

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** 5-Fluoro-2-Deoxycytidine (FdCyd)
- **OTHER:** Laboratory Biomarker Analysis
- **OTHER:** Pharmacological Study
- **DRUG:** Tetrahydrouridine (THU)

## Key facts

- **NCT ID:** NCT00359606
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-04
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2015-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00359606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00359606, "5-Fluoro-2'-Deoxcyctidine and Tetrahydrouridine to Treat Patients With Advanced Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00359606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*